Overall rank by patents
#24,577
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Invicta Medical, Inc.
USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
11
Total patents granted
4
CPC technology areas
24.3
Avg claims per patent
+167%
5-year filing velocity
The verdict
Invicta holds 11 US patents across 4 technology areas, rank #24,577 of 50,000 tracked assignees.
- #24,577
- of 50,000 US assignees by volume
- Top 20%
- by Innovation Score (46.9/100)
- 24.3
- avg claims per patent
- +167%
- filing velocity, last 5 yrs
Portfolio overview
Invicta Medical, Inc. has been granted 11 US utility patents between 2017 and 2025, placing Invicta Medical, Inc. at rank #24,577 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.3 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Invicta Medical, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Invicta sits between International Textile Group, Inc. (11 patents, rank #24,573) and Istari Digital, Inc. (11 patents, rank #24,581) - the closest US assignees by grant volume. The composite Innovation Score of 46.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 3 in the 2015–2019 window, a +167% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Invicta Medical, Inc.'s 24.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Invicta Medical, Inc. against peers pursuing similar technology classes.
Who files at Invicta's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- International Tex…
International Textile Group, Inc.
11 patents
- Intevep
Intevep, S.A.
11 patents
- Intuition Robotics
Intuition Robotics, Ltd.
11 patents
- Investigacion y T…
Investigacion y Tecnologia de Uva de Mesa S.L.
11 patents
- Ioxus
Ioxus, Inc.
11 patents
- Irwin Research an…
Irwin Research and Development, Inc.
11 patents
- Isolation Equipme…
Isolation Equipment Services Inc.
11 patents
- Istari Digital
Istari Digital, Inc.
11 patents
- Invicta Medical ◀
Invicta Medical, Inc.
11 patents
What this shows Invicta holds 11 patents at rank #24,577, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Invicta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 20% higher than 80% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 9.1% |
| 2019 | 2 | 18.2% |
| 2022 | 1 | 9.1% |
| 2023 | 1 | 9.1% |
| 2024 | 3 | 27.3% |
| 2025 | 3 | 27.3% |
Which technologies does Invicta Medical, Inc. patent most?
Top 4 of 4 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Velocity Accelerating
Frequently Asked Questions
How many patents does Invicta Medical, Inc. hold?
Invicta Medical, Inc. holds 11 US granted patents filed between 2017 and 2025, spanning 4 technology areas.
What is Invicta Medical, Inc.'s Innovation Score?
Invicta Medical, Inc. has an Innovation Score of 46.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Invicta Medical, Inc. focus on?
Invicta Medical, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 11 patents. The company has filed patents in 4 CPC subclasses total.
Is Invicta Medical, Inc.'s patent filing rate increasing or decreasing?
Invicta Medical, Inc.'s recent filing velocity is +167% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Invicta Medical, Inc.'s patents?
Invicta Medical, Inc.'s patents average 24.3 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Invicta Medical, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Invicta's 11 grants land it in the top 20% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Invicta ranks #24,577 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.